178 related articles for article (PubMed ID: 12527113)
1. Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization.
Lefebvre T; Ferreira S; Dupont-Wallois L; Bussière T; Dupire MJ; Delacourte A; Michalski JC; Caillet-Boudin ML
Biochim Biophys Acta; 2003 Jan; 1619(2):167-76. PubMed ID: 12527113
[TBL] [Abstract][Full Text] [Related]
2. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
Smet-Nocca C; Broncel M; Wieruszeski JM; Tokarski C; Hanoulle X; Leroy A; Landrieu I; Rolando C; Lippens G; Hackenberger CP
Mol Biosyst; 2011 May; 7(5):1420-9. PubMed ID: 21327254
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress induces transient O-GlcNAc elevation and tau dephosphorylation in SH-SY5Y cells.
Kátai E; Pál J; Poór VS; Purewal R; Miseta A; Nagy T
J Cell Mol Med; 2016 Dec; 20(12):2269-2277. PubMed ID: 27456536
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors.
Lim S; Haque MM; Nam G; Ryoo N; Rhim H; Kim YK
Int J Mol Sci; 2015 Aug; 16(9):20212-24. PubMed ID: 26343633
[TBL] [Abstract][Full Text] [Related]
5. Prediction of human tau 3D structure, and interplay between O-β-GlcNAc and phosphorylation modifications in Alzheimer's disease: C. elegans as a suitable model to study these interactions in vivo.
Ahmad W; Shabbiri K; Ahmad I
Biochem Biophys Res Commun; 2020 Jul; 528(3):466-472. PubMed ID: 32499112
[TBL] [Abstract][Full Text] [Related]
6. Does O-GlcNAc play a role in neurodegenerative diseases?
Lefebvre T; Guinez C; Dehennaut V; Beseme-Dekeyser O; Morelle W; Michalski JC
Expert Rev Proteomics; 2005 Apr; 2(2):265-75. PubMed ID: 15892570
[TBL] [Abstract][Full Text] [Related]
7. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.
Yuzwa SA; Shan X; Macauley MS; Clark T; Skorobogatko Y; Vosseller K; Vocadlo DJ
Nat Chem Biol; 2012 Feb; 8(4):393-9. PubMed ID: 22366723
[TBL] [Abstract][Full Text] [Related]
8. [Effects of Xixin decoction on enzymes related to O-GlcNAc glycosylation of tau proteins in the brain of rats with sporadic Alzheimer's disease].
Diwu Y; Tian J; Shi J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1442-7. PubMed ID: 24144743
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAc transferase is in a functional complex with protein phosphatase 1 catalytic subunits.
Wells L; Kreppel LK; Comer FI; Wadzinski BE; Hart GW
J Biol Chem; 2004 Sep; 279(37):38466-70. PubMed ID: 15247246
[TBL] [Abstract][Full Text] [Related]
10. Identification of N-acetyl-d-glucosamine-specific lectins from rat liver cytosolic and nuclear compartments as heat-shock proteins.
Lefebvre T; Cieniewski C; Lemoine J; Guerardel Y; Leroy Y; Zanetta JP; Michalski JC
Biochem J; 2001 Nov; 360(Pt 1):179-88. PubMed ID: 11696006
[TBL] [Abstract][Full Text] [Related]
11. The potential role of tau protein O-glycosylation in Alzheimer's disease.
Robertson LA; Moya KL; Breen KC
J Alzheimers Dis; 2004 Oct; 6(5):489-95. PubMed ID: 15505370
[TBL] [Abstract][Full Text] [Related]
12. Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc.
Wells L; Vosseller K; Hart GW
Science; 2001 Mar; 291(5512):2376-8. PubMed ID: 11269319
[TBL] [Abstract][Full Text] [Related]
13. Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line.
Lefebvre T; Alonso C; Mahboub S; Dupire MJ; Zanetta JP; Caillet-Boudin ML; Michalski JC
Biochim Biophys Acta; 1999 Oct; 1472(1-2):71-81. PubMed ID: 10572927
[TBL] [Abstract][Full Text] [Related]
14. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.
Gao Y; Wells L; Comer FI; Parker GJ; Hart GW
J Biol Chem; 2001 Mar; 276(13):9838-45. PubMed ID: 11148210
[TBL] [Abstract][Full Text] [Related]
15. Effect of xixin decoction on O-linked N-acetylglucosamine glycosylation of tau proteins in rat brain with sporadic Alzheimer disease.
Diwu Y; Tian J; Shi J
J Tradit Chin Med; 2013 Jun; 33(3):367-72. PubMed ID: 24024334
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
Gong CX; Liu F; Iqbal K
Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
[TBL] [Abstract][Full Text] [Related]
17. UDP-N-acetylglucosaminyl transferase (OGT) in brain tissue: temperature sensitivity and subcellular distribution of cytosolic and nuclear enzyme.
Okuyama R; Marshall S
J Neurochem; 2003 Sep; 86(5):1271-80. PubMed ID: 12911634
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
[TBL] [Abstract][Full Text] [Related]
19. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
20. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
Whelan SA; Hart GW
Circ Res; 2003 Nov; 93(11):1047-58. PubMed ID: 14645135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]